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Abstract 
Background: Chemokine C-C motif ligand 1 (CCL1) accumulates C-C motif chemokine receptor 8 positive leuko-
cytes to the inflammatory sites. Single-nucleotide polymorphisms in the chemokine CCL1 gene are associated with 
exacerbation of chronic obstructive lung disease. However, it is unclear whether CCL1 has immunomodulatory func-
tions during pulmonary inflammation. This study aimed to elucidate this issue using newly generated transgenic mice 
that express CCL1 in the lungs (SPC-CCL1 mice).
Methods: To evaluate the phenotypes of these mice, lung section and bronchoalveolar lavage (BAL) fluid analyses 
were performed. We intratracheally administered lipopolysaccharide (LPS) or Mycobacterium bovis as a model of acute 
or chronic lung inflammation, respectively.
Results: No histological differences were observed between lung tissue from SPC-CCL1 Tg and wild-type mice in the 
resting condition and after LPS administration. In the resting condition, the total BAL cell concentration was lower in 
SPC-CCL1 Tg mice than in wild-type mice (P = 0.0097). Flow cytometric analyses showed that SPC-CCL1 Tg mice had 
fewer F4/80-positive cells than wild-type mice (P = 0.0278). After intratracheal LPS administration, CCL1 overexpres-
sion changed neither the total numbers nor population of BAL cells. After mycobacterial administration, pulmonary 
granuloma formation was significantly enhanced. The degree of Immunostaining for endoplasmic reticulum to 
nucleus signaling 1, a molecule associated with granuloma formation and endoplasmic reticulum stress, was sig-
nificantly enhanced in the granuloma regions of SPC-CCL1 mice treated with Mycobacterium, compared to those of 
wild-type mice.
Conclusions: CCL1 overexpression in the lungs did not change the acute inflammatory response induced by LPS, 
but enhanced granuloma formation after mycobacterial treatment, possibly through enhancing endoplasmic reticu-
lum stress.
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Background
Chemokines constitute a family of mediators of inflam-
mation and immunity, which are specifically involved in 
the regulation of immune defense and in immune system 
housekeeping (Baggiolini 2001; Teran 2000). Chemokine 
C-C motif ligand 1 (CCL1) is one of the genes that reside 
in a CCL subfamily chemokine gene cluster on chromo-
some 17q11.2-q12 in humans (Rollins 1997). CCL1 is 
known to be produced by activated monocytes/mac-
rophages, T lymphocytes (Th1, Th2, Tc), and endothelial 
cells (Rollins 1997; Tiffany et al. 1997; Wilson et al. 1988). 
It mainly acts as a potent chemoattractant for mono-
cytes/macrophages, lymphocytes, and neutrophils and is 
thought to play a major role in inflammatory processes 
(Luo et al. 1996; Miller and Krangel 1992; Rollins 1997). 
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Furthermore, C-C motif chemokine receptor 8 (CCR8), 
a receptor of CCL1, is known to be expressed in mono-
cytes/macrophages, Th2, and regulatory T lymphocytes 
(Treg) (Rollins 1997; Trebst et  al. 2003; Zingoni et  al. 
1998).
Prior to this study, we demonstrated that single-
nucleotide polymorphisms (SNPs) in the CCL1 gene are 
associated with chronic obstructive pulmonary disease 
(COPD) exacerbation (Takabatake et  al. 2006), that is 
mainly caused by respiratory tract infection and induces 
acute worsening of symptoms from the usual stable state 
(Hurst et al. 2006; Patel et al. 2002; Wilkinson et al. 2006). 
Carriage of the risk allele for this SNP (National Center 
for Biotechnology Information SNP: rs2282691: A allele) 
predisposes patients with COPD to exacerbation. In 
contrast, carriage of another allele (the T allele) is asso-
ciated with relative protection from exacerbation (Taka-
batake et  al. 2006). Because this SNP is located in the 
promoter region of the CCL1 gene, where the C/EBPβ 
transcription factor binds, this phenomenon appears 
to be determined by differences in affinity between C/
EBPβ and the DNA motif (Takabatake et  al. 2006). C/
EBPβ is a key transcription factor for acute-phase mol-
ecules in response to acute lung injury or infection, and 
the cardinal role of C/EBPβ is to up-regulate a set of C/
EBPβ-regulated genes, including the CCL1 gene, leading 
to the subsequent activation of the innate immune sys-
tem and inflammatory response (Didon et al. 2005; Poli 
1998). CCL1 has been suggested to play a key role in host 
defense mechanisms, and up-regulation of CCL1 may 
defend against infections.
Although the role of CCL1 are investigated, it is still 
unclear how CCL1 modulates acute and chronic inflam-
mations in the lung. Therefore, we sought to clarify the 
roles of CCL1 in the lung using newly engineered trans-
genic (Tg) mice (SPC-CCL1 Tg mice). We evaluated the 
phenotype of these mice and the in vivo effects of CCL1 
overexpression on acute and chronic lung inflammation.
Methods
Construction of the SPC‑CCL1 plasmid vector
The 3.7 hSP-C/SV-40 plasmid used in this study was 
kindly provided by Jeffrey A. Whitsett, (Children’s Hos-
pital Medical Center, Cincinnati, Ohio, USA) (Glasser 
et al. 1988, 1991). This plasmid is composed of a 3.7-kb 
flanking sequence of the human SP-C promoter and the 
SV-40 small T intron as a polyadenylation signal (Geraci 
et al. 1999; Korfhagen et al. 1990). This construct enables 
specific expression of transgenes in the distal lung epithe-
lium and alveoli (Geraci et al. 1999; Glasser et al. 1991).
The murine CCL1 mRNA sequence was ascertained 
by searching the NCBI library (NM_011329) and the 
Ensembl genome browser (ENSMUSG00000020702). 
The mRNA of murine CCL1 consists of 514 bp, includ-
ing the untranslated region and the coding sequence. 
We prepared an insert genome sequence compris-
ing 283  bp, including the entire coding sequence, and 
added restriction enzyme sites, SalI (GTCGAC) and 
EcoRI (GAATTC), before and after the sequence. Invit-
rogen™ assisted in sequence manufacture. The murine 
CCL1 cDNA was cloned into the SalI/EcoRI restriction 
site of the 3.7 hSP-C/SV-40 plasmid, creating the SPC-
CCL1 cDNA fusion gene (Fig.  1a). The proper orienta-
tion of the plasmid was confirmed using an ABI PRISM 
3130 Genetic Analyzer, and polymerase chain reaction 
(PCR) using Platinum Taq DNA polymerase (Invitrogen, 
Carlsbad, CA, USA) using specific primers. We designed 
specific primers across the sequence of CCL1 and SV40 
DNA (forward: TGT CCC TCT CCT ACG GAC AC, 
reverse: CCA CAG AAG TAA GGT TCC TTC ACA). 
These primers were also used to verify the genomic DNA 
sequence of the transgene in vivo.
Generation of SPC‑CCL1 Tg mice
The resultant plasmid was digested with SacI to gener-
ate 2.7-kb (pUC 18 DNA) and 4.4-kb (SPC-CCL1) linear 
fragments, which were microinjected into the pronuclei 
of fertilized C57BL/6 mouse eggs and implanted into a 
foster mother mouse to induce a pseudopregnancy. We 
commissioned the Research Laboratory for Molecular 
Genetics (Faculty of Medicine, Yamagata University) to 
generate transgenic mice.
The rooms were kept free of any pathogens. All mice 
were handled according to the guide for the care and 
use of laboratory animals of Yamagata University, and 
the study protocol was approved by the Animal Subjects 
Committee of Yamagata University (23068, 24068, 25068, 
26068, and 27068). The study was also performed in 
accordance with the Declaration of Helsinki.
Histological analysis
Mice were anesthetized by intraperitoneal injection of 
10  % pentobarbital (100  mg/kg body weight), and were 
sacrificed for collection of blood and excision of organs. 
The lungs were inflated intratracheally under constant 
positive pressure at 25 cm H2O with 4 % paraformalde-
hyde for fixation and resected to prepare paraffin-embed-
ded lung blocks for morphological examinations (Hirama 
et al. 2007). Other tissues were also fixed with 4 % para-
formaldehyde, and embedded into paraffin. Tissue sec-
tions were cut at a 3-μm thickness and placed on glass 
slides, subsequently stained with hematoxylin and eosin, 
and examined using a microscope (BX50F4; Olympus, 
Tokyo, Japan).
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Fig. 1 Generation of the CCL1 transgenic (Tg) mice using the surfactant protein C (SP-C) promoter. a The plasmid was composed of the 3.7-kb 
human SP-C promoter and the SV-40 small T intron. The murine CCL1 cDNA was cloned into the SalI/EcoRI restriction site, creating the SPC-CCL1 
cDNA fusion gene. The resultant plasmid was digested with SacI to generate 4.4-kb (SPC-CCL1) linear fragments, which were microinjected into 
the pronuclei of fertilized C57BL/6 mouse eggs and implanted into a foster mother mouse to induce a pseudopregnancy. b Gene expression of 
SPC-CCL1 and GAPDH evaluated by RT-PCR. CCL1 gene expression was confirmed by RT-PCR using specific primers. CCL1 gene expression was 
upregulated in the lungs of SPC-CCL1 Tg mice, but negative in those of wild-type (WT) mice. c Comparison of CCL1 levels in BAL fluid between Tg 
and WT mice. CCL1 concentrations were measured by ELISA. The levels of CCL1 in BAL fluid and serum were elevated in SPC-CCL1 Tg mice (gray 
bar) compared to WT mice (black bar). *P value <0.01. d Histological findings for the lungs (hematoxylin and eosin stain, ×200). No morphological 
changes were observed in the lungs of SPC-CCL1 Tg mice (right), compared to WT mice (left)
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Extraction of RNA and reverse transcription (RT)‑PCR
Total RNA was extracted from lung, heart, liver, and 
kidney tissues using TRIzol reagent (Invitrogen, Carls-
bad, CA, USA) according to the manufacturer’s pro-
tocol. RT was performed using SuperScript III reverse 
transcriptase (Invitrogen, Carlsbad, CA, USA) and gene 
expression was assessed by RT-PCR. The sequences of 
the specific primers were as follows: CCL1; identical to 
the primers described above, GAPDH; forward, CTT 
CAC CAC CAT GGA GAA GGC; reverse, GGC ATG 
GAC TGT GGT CAT GAG, CCR8; forward, TGG TCT 
TCC TGC CTC GAT GGA; reverse, CAG GCT GTT 
CCC CAG AAG GCC CA. PCR products were elec-
trophoresed in 2.0  % agarose gels containing ethidium 
bromide, and visualized digitally with an ultraviolet illu-
minator (AB1500 Printgraph and AE 6905H Image Saver 
HR; ATTO Bioscience, Tokyo, Japan) (Machiya et  al. 
2007).
Preparation of blood
Whole blood was drawn by direct puncture of the infe-
rior vena cava in mice, which had been deeply anesthe-
tized with intraperitoneal 10 % pentobarbital (100 mg/kg 
body weight). Blood samples were used for three different 
purposes; whole blood cell counts, serum collection, and 
preparation of white blood cell suspensions. For whole 
blood cell counts, blood was collected into tubes con-
taining ethylenediaminetetracetic acid (EDTA), and was 
analyzed using a whole blood counter (Celltacα; Nihon 
Kohden, Tokyo, Japan). For serum collection, blood was 
collected into tubes without EDTA, and thereafter indi-
vidual serum samples were separated from the clotted 
blood by centrifugation and stored at −80  °C until the 
assays were performed. For preparation of white blood 
cell suspensions, whole blood was collected into tubes 
containing EDTA, blood cell suspensions were prepared 
after hemolysis of erythrocytes by distilled water, and the 
resultant suspensions were used for flow cytometry.
Bronchoalveolar Lavage (BAL) procedure
Mice were anesthetized and a 20-gauge metallic cath-
eter was inserted into the trachea. BAL was performed 
by administering 1  ml of Hanks’ balanced salt solution 
(HBSS) containing 0.5 mM EDTA 3 times with a syringe. 
These manipulations were performed gently to avoid arti-
ficial lung injury. Total BAL cell numbers were counted 
under a light microscope using a hemocytometer. Frac-
tions of the BAL cells were attached to glass slides by 
cytospinning at 1000 rpm for 5 min (Shandon Cytospin 
2 Cytocentrifuge; Thermo, Waltham, MA, USA), and 
stained with a Diff-Quick solution (International Rea-
gents Corp., Kobe, Japan) for differential cell counts 
(Hirama et  al. 2007). The remaining cells were divided 
from the BAL fluid by centrifugation at 1200  rpm for 
5 min, supernatants were stored at −80 °C until evalua-
tion by ELISA, and cell suspensions were used for flow 
cytometry.
Biochemical analysis of BAL fluid and serum
Murine CCL1, interleukin-6 and tumor necrosis factor-
alpha in the BAL fluid and serum were measured by 
ELISA (Quantikine; R&D Systems, Minneapolis, MN, 
USA), according to the manufacturer’s protocols.
Flow cytometry
Cell surface markers of BAL cells (F4/80, CD11b, Gr-1) 
from WT or SPC-CCL1 Tg mice were analyzed by flow 
cytometry. Cells were resuspended in fluorescence-
activated cell sorter (FACS) buffer (PBS supplemented 
with 0.2  % BSA, 0.01  % sodium azide). BAL cells were 
stained with FITC-labeled F4/80 antibody (AbD; Sero-
tec, Kidlington, UK); PerCP-labeled CD11b antibody 
(BD Pharmingen, CA, USA), PE-labeled Gr1 antibody 
(BD Pharmingen, CA, USA), or an isotype control (BD 
Pharmingen, CA, USA) at a concentration of 10  µg/ml 
at 4 °C for 30 min in the dark. Stained cells were washed 
once in FACS buffer and subjected to flow cytometric 
analysis using a FACS Canto II (BD Biosciences, CA, 
USA) (Sato-Nishiwaki et  al. 2013). Data were analyzed 
using DIVA software (BD Bioimaging Systems, MD, 
USA) and FlowJo 7.6.1 (Tree Ster, Inc., Ashland, OR, 
USA).
Acute lung inflammation model
Mice were anesthetized by intraperitoneal injection of 
10 % pentobarbital (80 mg/kg body weight), and the tra-
chea was intubated with a 22-gauge cannula. Lipopoly-
saccharide (LPS, 2  mg/kg body weight) derived from 
Escherichia coli O55: B5 (SIGMA-ALDRICH. St. Louis, 
MO, USA) in isotonic sodium chloride solution was 
intratracheally administered via a cannula at a determi-
nate amount (50 µl/mouse) (Chen et al. 2013). Mice were 
sacrificed after 6, 24, or 72  h from administration, and 
were evaluated for histological findings of lung, BAL cell 
count, and cell differentials.
Chronic lung injury model
Bacille de Calmette et Guérin (BCG, 6  ×  106/mouse) 
derived from Mycobacterium bovis (Tokyo 172 strain) 
(Japan BCG Laboratory. Tokyo, Japan) in isotonic sodium 
chloride solution was intratracheally administered via a 
cannula at a determinate amount (100 µl/mouse) to anes-
thetized mice (Fulton et  al. 2000; Tokairin et  al. 2008). 
Mice were sacrificed after 28  days from administration 
for the preparation of pathological samples and the iso-
lation of total RNA from the lungs. In the pathological 
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analyses, three digitized tissue images were randomly 
taken using a microscope system at the 10× magnifica-
tion from all lobes of each mouse, and the total number 
of granulomas was counted.
Immunohistochemistry
Paraffin-embedded sections (3  μm thick) were cut and 
placed on glass slides. For detection of immunoglobulin 
(Ig), sections were incubated with antibodies to horse-
radish peroxidase-labeled mouse IgG (Promega Corp., 
Madison, WI, USA) at 1:250 dilution. For detection of 
endoplasmic reticulum to nucleus signaling (Ern)-1, 
sections were incubated with antibodies to phosphoryl-
ated Ern1, also known as inositol-requiring enzyme-1a 
(IRE1a) (Novus Biologicals, Littleton, CO, USA) at 1:1000 
dilution, followed by horseradish peroxidase-labeled 
anti-rabbit IgG (Promega Corp., Madison, WI, USA) at 
1:200 dilution. Color development was performed using 
the DAKO Liquid DAB + Substrate Chromogen System 
(Dako, Glostrup, Denmark). Immunostaining of all sec-
tions was performed simultaneously, to avoid variation 
due to differences in staining conditions. Cell nuclei were 
stained with hematoxylin.
To evaluate the positivity of IgG and Ern1, intensities of 
IgG and Ern1 immunohistochemistry in each granuloma 
were scored according to the scoring system described 
in the previous literature with some modification (Serth 
et  al. 1995): 0, no staining at all; 1, staining in <5  % of 
cells; 2, staining in 5–10 % of cells; 3, staining in 11–39 % 
of cells; 4, staining in >40  % of cells. This assessment 
was performed in the twenty granulomas in each mice, 
and the mean was used for the representative value for a 
mouse.
Evaluation of bacterial burden after inoculation of BCG
As described above, BCG (6 × 106/mouse) was intratra-
cheally administrated to mice. DNA was isolated from 
removed lungs using Allprep DNA/RNA Mini Kit (QIA-
GEN). MBP70, a BCG genomic DNA, and Ywhaz, a 
genomic mouse DNA, was amplified using real-time 
PCR system (Kimura et  al. 2012). The sequences of the 
specific primers were as follows: MBP70; forward, ACC 
AGC ATC CTG ACC TAC CAC; reverse, CTT GAG 
GCT GTT ACC CTG ACC, and Ywhaz4; forward, GTA 
AAG TGC AGC CCA CGA CA; reverse, AGG AAG 
CGG CCT TAG ACC TT. The primers for Ywhaz were 
designed from the sequence between intron 1 and 2. 
The ratio of the PCR-amplification level in MBP to that 
in Ywhaz were considered as bacterial burden of BCG 
(Cousins et al. 1992; de Assuncao et al. 2014). Data were 
expressed as fold change compared to wildtype mice.
Statistical analysis
The results are expressed as mean ±  standard deviation 
(SD). Student’s t test was used to evaluate differences in 
means. The non-parametric Mann–Whitney U test was 
used to compare variables that were not normally distrib-
uted. All statistical analyses were performed using JMP 
version 9 software (SAS Institute Inc., Cary, NC, USA). 
Statistical significance was defined as P < 0.05.
Results
Confirmation of CCL1 mRNA overexpression
Three transgenic founders (lines 6, 8, and 63) were gen-
erated, as confirmed by PCR of genomic DNA. CCL1 
mRNA expression of SPC-CCL1 Tg mice was confirmed 
by RT-PCR using specific primers. Transgene expression 
of CCL1 was detected only in the lungs of SPC-CCL1 
Tg mice, and no CCL1 expression was observed in other 
organs, or in WT mice. Representative images of CCL1 
and GAPDH expression in line 63 are shown in Fig. 1b. 
The levels of CCL1 in BAL fluid and serum were signifi-
cantly elevated in SPC-CCL1 Tg mice, compared with 
WT mice (Fig. 1c). The CCL1 concentration in the BAL 
fluid was lower in the other two lines of transgenic mice 
than in line 63 (data not shown). Thus, line 63 was used 
for the following experiments.
Evaluation of phenotypes
No neonatal death was observed in SPC-CCL1 mice, and 
the survival rate was similar to that of WT mice (data 
not shown). The general appearance of SPC-CCL1 Tg 
mice was not obviously different from that of WT mice 
(data not shown). No morphological differences in lung 
tissue were observed between SPC-CCL1 Tg mice and 
WT mice (Fig. 1d). Histological findings for other tissues 
(heart, thymus, liver, spleen, pancreas, kidney, adrenal 
gland, and skin) did not differ significantly between SPC-
CCL1 Tg mice and WT mice (data not shown).
There were no significant differences in organ weight 
between SPC-CCL1 Tg mice and WT mice (Table 1). In 
the whole blood counts, SPC-CCL1 Tg mice and WT 
mice did not differ significantly in numbers of white 
blood cells or red blood cells, but the platelet count was 
significantly higher in SPC-CCL1 Tg mice than in WT 
mice (Table 1).
Analysis of BAL cell numbers and differential cell counts
Concentrations of BAL cells and total cell count were 
significantly lower in SPC-CCL1 Tg mice than in WT 
mice (Table  2). Furthermore, the number of mac-
rophages was lower in SPC-CCL1 Tg mice than in WT 
mice (Table 2).
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Analysis of surface markers by flow cytometry (FCM)
Dot plots of BAL cells by FCM are shown in Fig.  2. 
BAL cells of WT mice (Fig. 2a) and SPC-CCL1 Tg mice 
(Fig.  2b) were distributed by forward scatter (FSC) and 
side scatter (SSC). FSC and SSC were expressed on a 
log scale, and smaller objects (FSC  <  5000) were omit-
ted from analyses as debris. Cells regarded as alveolar 
macrophages (AMs) were enclosed hexagonal forms, 
and gated for analysis (Tailleux et  al. 2005). The results 
showed fewer AMs in SPC-CCL1 Tg mice than in WT 
mice.
Subsequently, the gated fractions of AMs of WT mice 
and SPC-CCL1 Tg mice were evaluated for expres-
sion of surface markers (F4/80 and CD11b) (Fig.  2c, 
d). Expression of F4/80 on AMs from SPC-CCL1 Tg 
mice was attenuated, compared with that of WT mice 
(Fig. 2e, Tg mice: 31.8 ± 4.8 %, WT mice: 39.6 ± 3.1 %, 
P  =  0.0278). However, expression of CD11b on AMs 
from SPC-CCL1 Tg mice remained unchanged, com-
pared with that of WT mice (Fig. 2f, Tg mice: 4.2 ± 1.7 %, 
WT mice: 4.2 ± 2.7 %, P = 0.9168).
Analysis of acute lung injury model
Mice were intratracheally administered LPS (2  mg/kg 
body weight) and sacrificed at 6, 24, or 72 h after admin-
istration. At 6 h after administration, inflammatory cells, 
such as neutrophils, had infiltrated the alveoli of both 
WT (Fig. 3a) and SPC-CCL1 Tg mice (Fig. 3b). Infiltra-
tion of inflammatory cells was almost equal between the 
two groups. At 72 h after administration, the alveoli were 
filled with inflammatory cells, particularly neutrophils, 
macrophages, and exudates. Histopathological findings 
did not show significant differences between LPS-treated 
SPC-CCL1 Tg mice (Fig. 3d) and WT mice (Fig. 3c).
Figure 3e shows a time course of change in BAL cells 
after LPS administration. However, CCL1 overexpres-
sion changed neither the total numbers nor population 
of BAL cells (Fig. 3e). In addition, the levels of interleu-
kin-6 and tumor necrosis factor-alpha in BAL fluid after 
LPS intratracheal administration were not different in 
between WT and Tg mice (Table 3).
Analysis of chronic lung inflammation model
The lungs of WT and Tg mice were infected with M. 
bovis (BCG) to produce chronic pulmonary inflamma-
tion. Compared to the lungs of BCG-infected WT mice 
(Fig. 4a), granuloma formation was increased in Tg mice 
(Fig.  4b). Quantification was performed as described in 
the “Methods”, and the difference was confirmed (Fig. 4c). 
There were no significant bacterial burdens between WT 
and Tg mice (1.13  ±  0.60 fold vs wild type, P  =  0.74, 
n = 4 in each group).
Antibody-mediated immunity is reported to be impor-
tant for mycobacterial infection (Chan et  al. 2014). 
Immunohistochemical analysis using an antibody against 
IgG revealed more IgG-positive cells in the granuloma-
tous lesions of BCG-treated Tg mice than in those of 
WT mice [Fig.  5a, b: IgG immunostaining score: WT, 
1.3 ± 0.6 (n = 6); Tg 2.7 ± 0.6 (n = 4); P < 0.05 Mann–
Whitney U test].
Enhanced endoplasmic reticulum (ER) stress in SPC‑CCL1 
transgenic mice after mycobacterial infection
Recently, the involvement of ER stress was reported in the 
pathogenesis of granuloma formation induced by Mycobac-
terium (Seimon et al. 2010). Immunohistochemical analysis 
showed that alveolar macrophages in the lungs of Tg mice 
Table 1 Comparisons of  organ weight/blood count 
between  wild-type (WT) and  SP-C CCL-1 transgenic (Tg) 
mice at resting condition
Values are given as the mean ± SD
Mann–Whitney U test
BW body weight, WBC white blood cell, RBC red blood cell
WT (n = 4) Tg (n = 4) P value
BW (g) 25.7 ± 2.9 24.5 ± 0.8 0.3865
Lung (g) 0.119 ± 0.009 0.118 ± 0.009 0.7728
Heart (g) 0.113 ± 0.006 0.114 ± 0.010 0.5637
Liver (g) 1.138 ± 0.102 1.101 ± 0.085 0.5637
Spleen (g) 0.074 ± 0.012 0.070 ± 0.006 0.2482
Kidney (g) 0.279 ± 0.048 0.244 ± 0.023 0.3865
Thymus (g) 0.035 ± 0.003 0.033 ± 0.006 0.5637
WBC (×102/µl) 54.20 ± 16.36 65.40 ± 25.19 0.3472
RBC (×104/µl) 981.6 ± 125.3 845.6 ± 44.8 0.0758
Hemoglobin (g/dl) 15.8 ± 1.8 13.7 ± 0.4 0.0740
Hematocrit (%) 46.6 ± 6.1 43.2 ± 1.7 0.3472
Platelet (×104/µl) 68.6 ± 14.6 88.5 ± 10.5 0.0283
Table 2 Comparison of  BAL cells between  wild-type (WT) 
and SP-C CCL-1 transgenic (Tg) mice at resting condition
Values are given as the mean ± SD
Mann–Whitney U test
BW body weight
WT (n = 16) Tg (n = 15) P value
BW (g) 25.8 ± 2.0 26.2 ± 2.8 0.6734
Collection volume (ml) 2.93 ± 0.07 2.93 ± 0.07 0.9471
Cell concentrations (×104/ml) 2.00 ± 0.73 1.37 ± 0.52 0.0097
Total cell count (×104) 8.16 ± 2.19 4.31 ± 1.24 0.0112
Macrophages (×104) 7.66 ± 1.33 4.31 ± 1.24 0.0103
Neutrophils (×104) 0.46 ± 0.54 0.00 ± 0.00 0.1349
Lymphocytes (×104) 0.04 ± 0.06 0.00 ± 0.00 0.2688
Eosinophils (×104) 0.00 ± 0.00 0.00 ± 0.00 –
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Fig. 2 Flow cytometric (FCM) plots of BAL cells and alveolar macrophages. Representative schemas for dot plots for FCM are shown. BAL cells of WT 
mice (a) and SPC-CCL1 Tg mice (b) were distributed by forward scatter (FSC) and side scatter (SSC). Cells regarded as alveolar macrophages were 
enclosed hexagonal form. Alveolar macrophages were decreased in SPC-CCL1 Tg mice compared to WT mice. FSC and SSC were expressed on a log 
scale, and smaller objects (FSC < 5000) were omitted from analyses as debris. The fraction of macrophages was gated and the surface markers of WT 
mice and SPC-CCL1 Tg mice were evaluated. The gated fractions of AMs from WT mice (c) and SPC-CCL1 Tg mice (d) were distributed by FITC-F4/80 
and PerCP-CD11b. e F4/80-positive cells were decreased in SPC-CCL1 Tg mice (gray bar) compared to WT mice (black bar). f CD11b-positive cells 
remained unchanged compared to WT mice. *P value <0.05 compared to WT mice
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treated with BCG were more positive for phosphorylated 
Ern1 than those of WT mice (Fig. 6c, d). The nuclei in gran-
uloma cells of BCG-treated Tg mice were more positive 
for phosphorylated Ern1 than those of WT mice [Fig. 6e, 
f: Ern1 immunostaining score: WT, 3.1 ± 0.1 (n = 6); Tg 
3.7 ± 0.1 (n = 4); P < 0.05 Mann–Whitney U test].
Fig. 3 Intratracheal administration of lipopolysaccharide (LPS) into the lungs of wild-type (WT) and SPC-CCL1 transgenic (Tg) mice. To produce a 
model of acute lung injury, mice were intratracheally administered LPS (2 mg/kg body weight). a WT mice, 6 h after administration. Inflammatory 
cells such as neutrophils had infiltrated the alveoli. b SPC-CCL1 Tg mice, 6 h after administration. Infiltration of inflammatory cells was also observed. 
c WT mice, 72 h after administration. The alveoli were filled with inflammatory cells, particularly neutrophils, macrophages, and exudates. d SPC-
CCL1 Tg mice, 72 h after administration. Histopathological findings did not show significant differences between LPS-treated SPC-CCL1 Tg mice and 
WT mice. e Time course of changes in BAL cells (left total cells, middle macrophages, right neutrophils) 6, 24 and 72 h after LPS administration. CCL1 
overexpression changed neither the total number nor population of BAL cells
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Discussion
In this study, we generated Tg mice that overexpress 
CCL1 specifically in the lungs (Fig. 1), and the activity of 
the transgene was verified by the high concentrations of 
CCL1 in the BAL fluid and serum (Fig. 1c). The receptor 
for CCL1, CCR8, is not expressed on pulmonary epithe-
lium, endothelium, or fibroblast. Therefore, pulmonary 
expression using SP-C promoter thought to be usable to 
evaluate the immune reaction of CCR8-positive leuko-
cytes to CCL1, although the major source of CCL1 is dif-
ferent between CCL1 Tg and WT mice. Because we did 
not detect the gene expression of CCL1 in other organs 
of CCL1 mice (Fig. 1b), the elevation of CCL1 seems to 
be due to spill-over of lung CCL1. However, the number 
of BAL cells, particularly the number of AMs, was signifi-
cantly lower in these Tg mice than in WT mice (Table 2). 
In addition, F4/80, a macrophage differentiation marker, 
was significantly reduced on AMs recovered from the 
BAL from resting-state Tg mice compared to WT mice 
(Fig.  2). In the model of acute lung inflammation, the 
accumulation of inflammatory cells did not significantly 
differ between the lungs of WT and Tg mice (Fig.  3). 
Notably, in the model of chronic inflammation, forma-
tion of granulomas after BCG administration was signifi-
cantly enhanced in the lungs of Tg mice compared to WT 
mice (Fig. 4). Immunohistochemical analysis showed the 
higher levels of phosphorylated Ern1 in the alveolar mac-
rophages and nuclei of granuloma cells in BCG-treated 
CCL1 Tg mice than in WT mice (Fig. 6).
CCL1 mainly acts as a potent chemoattractant for 
monocytes/macrophages, lymphocytes, and neutro-
phils. Therefore, the accumulation of the leukocytes 
to the lungs was expected in the CCL1 Tg mice. How-
ever, against this prediction, the total cells and alveolar 
macrophages recovered from BAL were significantly 
reduced in SPC-CCL1 Tg mice. The mechanism for 
this phenomenon has not been elucidated. In the lungs 
of these Tg mice, CCL1 is constitutively expressed, and 
a high level of CCL1 is maintained. Thus, in these mice, 
lung cells are chronically exposed to a high level of CCL1. 
Although acute chemotactic effects of CCL1 on inflam-
matory cells have been shown by several investigators 
(Doyle and Murphy 1999; Luo et  al. 1994; Miller and 
Krangel 1992; Tiffany et  al. 1997), the chronic effects 
of CCL1 have not been investigated. This difference in 
exposure of the cells to CCL1, acute or chronic, may alter 
the cellular response to this chemokine. Furthermore, 
chronic exposure to CCL1 might alter the expression 
of its receptor, CCR8, or the status of downstream mol-
ecules associated with CCL1-CCR8 signal transduction. 
However, we could not detect the expression of CCR8 in 
lung tissue or BAL cells of both CCL1 Tg and WT mice 
using RT-PCR methods, probably due to the low expres-
sion of CCR8 in lung tissue and alveolar macrophages, 
although CCR8 expression was positive in thymus of 
WT and CCL1 Tg mice (data not shown). Because we 
could not find any literatures describing the expression 
of CCR8 in the murine alveolar macrophages, the expres-
sion of CCR8 may be lost during the process to terminal 
differentiation of alveolar macrophages in mice. CCR8 
expression in circulating monocyte should be examined 
using flow cytometry technique in the future in CCL1 Tg 
mice.
Total BAL cells, especially alveolar macrophages, and 
expression of the surface marker, F4/80, in AMs of Tg 
mice was significantly reduced (Table  2; Fig.  2e). F4/80 
has been established as a specific cell surface marker for 
murine macrophages (Austyn and Gordon 1981; Mor-
ris et al. 1991), and is known to be a member of the epi-
dermal growth factor-seven-transmembrane-domain 
family. As the precursors of tissue macrophages, blood 
monocytes express less F4/80 than mature macrophages 
(Gordon et al. 1992). CD11b is expressed on the surface 
of monocytes, macrophages, NK cells, and granulocytes. 
AMs express less CD11b than their monocytic precursors 
(Senft et al. 2007). In the present study, F4/80 expression 
was reduced in the AMs of SPC-CCL1 Tg mice com-
pared to those of WT mice. However, the mechanisms 
for decreasing numbers and surface markers of alveolar 
macrophages in CCL1 Tg mice was unclear. The alveolar 
macrophage numbers and functions are known to be reg-
ulated by hematopoietic growth factors such as M-CSF 
and GM-CSF (Shibata et al. 2001a, b). CCL1 may modu-
late the expression of these growth factors or their recep-
tors. In future work, we will need to evaluate the levels of 
M-CSF, GM-CSF, receptors for M-CSF and GM-CSF, and 
the transcription factors that regulate the differentiation 
Table 3 Comparison of  Interleukin-6 (IL-6) and  tumor 
necrosis factor-alpha (TNF-alpha) in  bronchoalveolar lav-
age fluid after  intratracheal administration of  lipopoly-
saccharide between wild-type (WT) and SP-C CCL-1 trans-
genic (Tg) mice
Values are given as the mean ± SD
Mann–Whitney U test
Time point (h) WT (n = 5) Tg (n = 5) P
IL-6 0 18.6 ± 6.2 19.8 ± 6.4 0.77
6 254.2 ± 90.7 385.6 ± 107.8 0.63
24 1336.0 ± 500.3 1500.6 ± 331.2 0.56
72 915.6 ± 377.9 1141.0 ± 423.0 0.4
TNF alpha 0 18.0 ± 7.6 22.0 ± 7.5 0.43
6 563.2 ± 198.1 728.6 ± 218.6 0.26
24 1576.4 ± 546.8 1468.8 ± 589.9 0.77
72 315.8 ± 126.6 417.2 ± 174.8 0.32
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and functions of macrophages, such as PU.1, MafB, and 
interferon regulatory factor-8 (Sato-Nishiwaki et al. 2013; 
Shibata et al. 2001a; Tamura et al. 2000).
In the present study, CCL1 overexpression did not alter 
accumulation of inflammatory cells after LPS stimulation 
(Fig.  3), although the baseline number of alveolar mac-
rophages were significantly reduced (Table 2). This result 
was consistent with a previous report that demonstrated 
a lack of induction of CCL1 by stimulation with LPS, 
IFN-γ, interleukin-1beta (IL-1β), tumor necrosis factor 
alpha (TNFα), IL-4, IL-13, IL-10, IL-6, IL-18, and combi-
nations thereof in human monocytes, induction of CCL1 
in monocytes, and the requirement for engagement of 
FcγR II following exposure to IL-1β or LPS (Sironi et al. 
2006). CCL1 did not play major roles in this acute lung 
inflammation model.
CCL1 is suggested to be involved in the pathogen-
esis of mycobacterial infection, one of the most impor-
tant chronic inflammation in the lung (Yu et  al. 2012). 
Increase of CCL1 was reported in the animal experimen-
tal model of granuloma by Mycobacterium (Chiu et  al. 
2003). Seimon et al. demonstrated induction of ER stress 
and upregulation of Ern1 in granuloma cells by admin-
istration of M. tuberculosis to mice (Seimon et al. 2010). 
Fig. 4 Intratracheal administration of Mycobacterium into the lungs of wild-type (WT) and SPC-CCL1 transgenic (Tg) mice. To produce a model of 
chronic lung inflammation, mice were intratracheally administered Bacille de Calmette et Guérin (BCG). a Representative lung image of WT mice, 
28 days after administration. b Representative lung image of SPC-CCL1 Tg mice, 28 days after administration. Enhanced granuloma formation was 
observed in the lungs of Tg mice, compared to WT mice c. *P value <0.05 compared to WT mice
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In the present study, we demonstrated the enhanced 
phosphorylation of Ern1 in the granulomas of CCL1 Tg 
mice (Fig. 6). To the best of our knowledge, there are no 
studies that have investigated the relationship between 
CCL1 and Ern1. However, it has been reported that over-
expression of CCL2, another chemokine, induces ER 
stress in a preadipocyte cell line. Inhibition of ER stress 
by taurursodeoxycholate or knockdown of Ern1 inhibited 
CCL2-induced protein caused autophagy and adipogen-
esis (Younce and Kolattukudy 2012). Increase of reactive 
oxygen species (ROS) is suggested to be involved in one 
of the mechanism governing CCL2-induced ER stress 
(Younce and Kolattukudy 2012). Because CCL1 also 
induces reactive oxygen in the presence of LPS in a dose-
dependent manner (Reimer et  al. 2011), it is possible 
that the increase of ROS enhances the ER stress in CCL1 
Tg mice. The mechanism governing the upregulation of 
Ern1 in the BCG-treated Tg mice needs to be elucidated 
with the precise in vitro experiments in the future.
Ern1 possesses an intrinsic kinase activity and an 
endoribonuclease activity, and it is important in altering 
gene expression in response to endoplasmic reticulum-
based stress signals. Although it has not been elucidated 
whether ER stress plays a beneficial role in the host 
response to infection, ER stress interacts with and regu-
lates signaling intermediates involved in the activation 
of the innate and adaptive immune responses (Muralid-
haran and Mandrekar 2013). It has been reported that 
Ern1 is necessary for the development of adaptive 
immune B cells, terminally differentiated plasma cells 
(Iwakoshi et  al. 2003; Zhang et  al. 2005). As shown in 
Fig.  5, immunoglobulin positive cells were increased in 
the granuloma of CCL1 Tg mice. Thus, enhanced phos-
phorylation of Ern1 may be essential for the alteration of 
immune status observed in the granuloma cells of BCG-
treated CCL1 Tg mice.
In the chronic lung inflammation model using 
intratracheal administration of BCG, granuloma forma-
tion was significantly increased in Tg mice. Since bacte-
rial burden after BCG inoculation was not significantly 
different between two groups (text in the “Results” sec-
tion), this enhanced formation of granuloma suggests 
the involvement of the hyper-response to biotic stimu-
lus in CCL1 Tg mice, not due to reduced bacterial kill-
ing capacity.
In conclusion, the present study demonstrated that 
CCL1 overexpression in the lungs altered the phenotypes 
of alveolar macrophages in terms of the number of alveo-
lar macrophages and surface marker expression at rest-
ing state in  vivo. Although over-expression of CCL1 in 
the lungs did not alter the acute inflammatory reaction, 
it altered the chronic inflammatory response induced by 
Mycobacterium, perhaps through enhancing ER stress. 
To the best of our knowledge, this study demonstrates 
novel in vivo roles for CCL1 in adaptive immunity such 
as granuloma formation.
Fig. 5 Immunohistochemical staining using an antibody to immunoglobulin G in the lungs of BCG-treated wild-type (WT) and SP-C CCL-1 trans-
genic (Tg) mice. Pulmonary immunoglobulin G was immunohistochemically stained in the lungs of WT (a, n = 6) and Tg mice (b, n = 4) 21 days 
after BCG administration, as described in the “Methods”. Representative images are shown. Black arrows indicate positive cells. Original magnification 
×800
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